Latest ArticlesDue to the frequent occurrence of oil spills and the large-scale production of oily wastewater, the treatment of oily sewage has become an important issue for sustainable development. Recently, materials prepared from lignocellulosic biomass (LCB) for oil-water separation have been found to be effective due to their high separation efficiency, good recyclability, and superior sustainability. However, few reviews have focused on the advantages and limitations of LCB for sewage treatment. This review summarizes the performance of modified LCB in oily wastewater treatment, in terms of the advanced modification methods applied and the structural dimensions of LCB materials according to the principle of superwetting oil-water separation. Research on the preparation technologies, separation mechanisms, and treatment efficiency of different LCB materials are briefly summarized, along with the characteristics of different LCB material types for oily wastewater treatment. Finally, the future prospects and challenges faced in the development of LCB materials are discussed.
Extracellular vesicles (EVs) are membrane vesicles secreted by cells, playing critical roles in mediating intercellular communications for various physiological and pathological processes. Most of the EV analysis is currently performed at the bulk level, obscuring the origin of the EVs and diverse characteristics of the individual extracellular vesicle. Technologies to analyze the extracellular vesicles at the single-cell and single-vesicle levels are needed to evaluate EV comprehensively and decode the heterogeneity underlying EV secretion. Microfluidic platforms that could control and manipulate fluids at the microscale provide an efficient way to achieve the aims. Various microfluidics-based technologies are emerging to realize single-cell EV secretion analysis and single EV analysis, which would be summarized in this mini-review.
Conversion of hexavalent chromium (Cr(Ⅵ)) to trivalent chromium (Cr(Ⅲ)) is an effective way to reduce its environmental risk, especially via photoreduction process. However, over a wide range of pH values, it is still a great challenge to achieve a high removal rate, and the disposal of produced Cr(Ⅲ) should be concerned. In this work, we implemented a high removal rate at 98% for Cr(Ⅵ) and total chromium (Cr(T)) over a wide pH range (4–10) through the synergistic effect of adsorption, photoreduction and immobilization on the surface of BiOBr0.25I0.75. The substitution of bromine by iodine reduced the adsorption energy of Cr(Ⅵ) on BiOBr0.25I0.75, promoting the adsorption of Cr(Ⅵ). Meanwhile, the introduced iodine upshifted the conduction band (CB), enhancing the reduction ability for Cr(Ⅵ) to Cr(Ⅲ). The negative surface of BiOBr0.25I0.75 can capture Cr(Ⅲ), achieving a high removal rate for Cr(T). The pH-independent feature for Cr(Ⅵ) and Cr(Ⅲ) removal make BiOBr0.25I0.75 a potential material for chromium-containing wastewater treatment. This work provides an effective strategy for removing chromium over a wide pH range.
Copper-catalyzed divergent annulations between α-diketones and alkynyl α-diketones have been achieved, delivering a series of highly functionalized and biologically important cis-hexahydro-2H-cyclopenta[b]furan (HCPF) and 2-hydroxydihydrofuran-3(2H)-one (HDFO) products with high levels of stereoselectivity under identical conditions. The protocol features the use of earth-abundant copper catalyst, mild conditions, shortening synthetic routes in constructing different molecular frameworks, and reducing the corresponding possible waste production. The substituents of the nucleophilic α-diketones play crucial roles in switching the reaction pathways.
Dimethyl ether (DME), as a promising alternative to diesel fuel and liquefied petroleum gas, has attracted considerable attention in catalysis domain. The catalytic direct synthesis of DME from syngas is an up-and-coming route but remains a challenge. In this work, we firstly prepared a Cu-embedded porous Al2O3 bifunctional catalyst (Cu@Al2O3-dp) by filling Cu-1, 3, 5-benzenetricarboxylate metal-organic framework (Cu-BTC MOF) with Al(OH)3 followed by a two-step calcination process (400 ℃ for 4 h and 600 ℃ for 1 h), exhibiting excellent catalytic performance for direct synthesis of DME from syngas. Cu@Al2O3-dp catalyst demonstrates much higher CO conversion (25.7% vs. 15.4%) and extremely higher DME selectivity (90.4% vs. 63.9%) with the increased catalytic stability compared to the supported Cu catalyst on MOF-derived porous Al2O3 (Cu/Al2O3) prepared by incipient wetness impregnation method, ascribed to the unique embedding-type structure, promoted Cu dispersion and stronger metal-support interaction. This work not only provides an efficient syngas-to-DME catalyst, but also paves a new way for designing highly-efficient core-shell bifunctional catalysts for diverse consecutive reactions.
Cardiac toxicity is one of the most common side effects of anticancer drugs. Cardiac toxicity results dysfunction of heart including hypotension, heart failure, and even cause death in extreme cases. The potential risk of cardiotoxicity is a huge concern in chemotherapeutics mediated cancer treatment. The individual with any pre-existing cardiac issues are excluded from clinical trials due to the potential risk of cardiotoxicity. Because of the potential cardiotoxicity, there is an emerging need for alternatives of some very potent anticancer drugs (doxorubicin/DOX, 5-fluorouracil/5FU, trastuzumab). While a patient is being treated with anticancer drugs, early blood screening, biomarker detection, and careful monitoring of cardiac functions are necessary to be able to avoid any irreversible cardiac damage. Therefore, early detection methodology to monitor cardiotoxicity in real-time, and a drug formulation that prevent interaction between drug and cardiac cell, seemingly have potential to mitigate the risk. In this review, we have summarized the cardiotoxicity of the most used anticancer drugs, their pathophysiology and some of the conventional and newer screening methods available to manage an individual patient in clinic. We have also incorporated our perspective on how a rationale designing of biomolecules can be used to overcome the cardiotoxicity generated chemotherapeutics.
As human stem cells with the special pluripotency play important roles in the innovative drug discovery and regenerative medicine, development of extracellular matrix (ECM) mimetics or functional materials that can support stem cell growth and propagation is of high significance. Despite numerous efforts spent, one major limitation restricting the wide applications of stem cells to the clinical translation is the lack of efficient strategies for low cost and large-scale stem cell production under xeno-free culture conditions. Herein, we reported a new strategy with peptides-modified polystyrene-based polymers coated onto the surface of coverslips for the growth and reproduction of human embryonic stem cells (hESCs). The modified peptides are the active parts of proteins which has been shown to contribute to the pluripotent stem cell attachment or proliferation. The peptides were linked to the glass coverslips coated by the polymer materials via chemical crosslinking, and the composite substrates successfully maintain the long-term growth of HUES-7, H7 and DF699. Our study shows that the coating of polystyrene-derived polymer modified by our developed peptides is a good matrix for long-term growth and reproduction of stem cells. This polystyrene-derived polymer substrate can be produced in large scale and stored for a long time. The most important thing is that it can support the growth of undifferentiated human pluripotent stem cells (hPSCs) for more than ten passages, which could provide a new and relatively easy way to amplify hESCs in vitro.
Compared with traditional photodynamic therapy (PDT), ultrasound (US) triggered sonodynamic therapy (SDT) has a wide application prospect in tumor therapy because of its deeper penetration depth. Herein, a novel MnSiO3-Pt (MP) nanocomposite composed of MnSiO3 nanosphere and noble metallic Pt was successfully constructed. After modification with bovine serum albumin (BSA) and chlorine e6 (Ce6), the multifunctional nanoplatform MnSiO3-Pt@BSA-Ce6 (MPBC) realized the magnetic resonance imaging (MRI)-guided synergetic SDT/chemodynamic therapy (CDT). In this nanoplatform, sonosensitizer Ce6 can generate singlet oxygen (1O2) to kill cancer cells under US irradiation. Meanwhile, the loaded Pt has the ability to catalyze the decomposition of overexpressed hydrogen peroxide (H2O2) in tumor microenvironment (TME) to produce oxygen (O2), which can conquer tumor hypoxia and promote the SDT-induced 1O2 production. In addition, MP can degrade in mildly acidic and reductive TME, causing the release of Mn2+. The released Mn2+ not only can be used for MRI, but also can generate hydroxyl radical (∙OH) for CDT by Fenton-like reaction. The multifunctional nanoplatform MPBC has high biological safety and good anticancer effect, which displays the great latent capacity in biological application.
Malignant tumors, with the characteristics of easy metastasis and recurrence, are a serious threat to health of mankind. It is urgent to develop promising clinical cancer targeted agents with combination of rapid diagnosis and efficient therapies. Compared with the conventional photosensitizing agents, the recent advances of nanoagents based on transition metal-oxide clusters possess unique structural and electronic properties, greatly improving cancer survival rate, meanwhile, keeping high contrast imaging. This review provides a brief introduction of metal-oxide clusters, including both nanoclusters to molecular clusters, specifically polyoxometalates (POMs). Subsequently, biocompatibility of metal-oxide clusters is emphasized from aspects of endocytosis, macropinocytosis, and phagocytosis. Through the classification of late and early transition metals oxide clusters, recent outcomes of light-guided nanoagents are represented with their intriguing chemical and optical properties in their diagnosing and photochemotherapy performance. It shed light on the summary of next generation multifunctional cancer targeting agents' developments as well as outlook of materials selection trends and research direction in the future.
A rhodium-catalyzed [4 + 3] cycloaddition reaction between N-methoxybenzamides and gem-difluorocyclopropenes is described. The reaction offers a mild and efficient approach towards the synthesis of fluorinated 2H-azepin-2-ones with broad substrate scope. A consecutive HOAc-assisted CN bond formation and fluorine elimination are involved as key steps for success as illustrated by detailed DFT studies.